40%-123% US Rx price variations found

13 February 2001

A US study, conducted by the Pennsylvania Psychological Association,has found that prices of six prescription drugs differed by about 40% on average but could vary as much as 123% among 88 state pharmacies.

The cheapest places to buy prescription drugs are either on-line or at discount stores, it said. Comparison shopping is the best way of ensuring consumers get the best deals, said Association chairman Salvatore Cullari, adding that consumers do not have to wait for the state or federal governments to pass new laws to save money.

The study compared costs for GlaxoSmithKline's oral diabetes agent Avandia (rosiglitazone); Pfizer's cholesterol-lowerer Lipitor (atorvastatin); AstraZeneca's proton pump inhibitor Prilosec (omeprazole); Eli Lilly's schizophrenia treatment Zyprexia (olanzapine); GSK's antidepressant Wellbutrin (bupropion) and Pfizer's antidepressant Zoloft (sertraline).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight